# CSBR (Champions Oncology, Inc.) - SEC EDGAR Financial Statements

> Champions Oncology, Inc. reported $60.66M in revenue and a net loss of $1.10M for the trailing twelve months ended July 31, 2026 (up 8.8% year over year), with a 49.8% gross margin and a -1.7% operating margin.

- Canonical: https://convexityos.com/fundamentals/CSBR
- Markdown: https://convexityos.com/fundamentals/CSBR.md
- SEC CIK: 0000771856
- Reporting currency: USD
- Latest filing period: July 31, 2026
- Last synced: Nov 20, 2026, 05:51 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000771856&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $60.66M | +8.8% YoY |
| Operating Income | TTM | -$1.02M | -1.7% margin |
| Net Income | TTM | -$1.10M | -1.8% net margin |
| Diluted EPS | TTM | -$0.08 | Split-adjusted |
| Free Cash Flow | TTM | -$6.14M | -10.1% FCF margin |
| Cash & ST Investments | Jul 31, 2026 | $4.36M | Total debt: $10.32M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $59.42M | $56.94M | $50.16M | $53.87M | $49.11M | $41.04M | $32.12M | $2.90M | $20.24M | $15.41M |
| Cost of Revenue | $30.90M | $28.39M | $29.40M | $29.53M | $23.63M | $21.45M | $17.00M | -- | -- | -- |
| **Gross Profit** | $28.52M | $28.55M | $20.75M | $24.34M | $25.48M | $19.59M | $15.12M | -- | -- | -- |
| Research & Development | $9.08M | $6.83M | $9.54M | $11.54M | $9.37M | $7.20M | $5.85M | $4.80M | $4.40M | $4.29M |
| Selling, General & Admin | $20.47M | $16.88M | $18.13M | $17.24M | $15.50M | $12.03M | $10.86M | $7.73M | $6.64M | $8.22M |
| Total Operating Expenses | -- | -- | -- | -- | -- | -- | $33.93M | $26.80M | $21.59M | $22.22M |
| **Operating Income** | -$1.14M | $4.55M | -$7.36M | -$5.26M | $607K | $366K | -$1.92M | $270K | -$1.35M | -$6.81M |
| **EBITDA** | $260K | $6.15M | -$5.46M | -$3.16M | $2.11M | $1.29M | -$1.10M | $876K | -$994K | -$6.64M |
| Income Before Tax | -$929K | $4.63M | -$7.31M | -$5.27M | $583K | $437K | -$1.96M | $231K | -$1.44M | -$6.87M |
| Income Tax Expense | $246K | -$75K | -$32K | $68K | $35K | $75K | $130K | $103K | $33K | $19K |
| **Net Income** | -$1.18M | $4.70M | -$7.28M | -$5.33M | $548K | $362K | -$2.09M | $128K | -$1.48M | -$6.88M |
| Basic EPS | -$0.08 | $0.34 | -$0.54 | -$0.39 | $0.04 | $0.03 | -$0.18 | $0.01 | -$0.13 | -$0.64 |
| **Diluted EPS** | -$0.08 | $0.33 | -$0.54 | -$0.39 | $0.04 | $0.02 | -$0.18 | $0.01 | -$0.13 | -$0.64 |
| Basic Shares Outstanding | 13.8M | 13.7M | 13.5M | 13.5M | 13.2M | 13.1M | 11.8M | 11.3M | 11.0M | 10.7M |
| Diluted Shares Outstanding | 13.8M | 14.3M | 13.5M | 13.5M | 14.2M | 14.6M | 11.8M | 14.1M | 11.0M | 10.7M |

### Income Statement (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $15.23M | $13.84M | $16.56M | $15.04M | $13.99M | $12.36M | $17.04M | $13.49M |
| Cost of Revenue | $7.53M | $6.81M | $8.83M | $7.26M | $8.00M | $7.27M | $6.62M | $7.43M |
| **Gross Profit** | $7.70M | $7.03M | $7.72M | $7.77M | $6.00M | $5.08M | $10.42M | $6.06M |
| Research & Development | $2.34M | $2.12M | $2.27M | $2.62M | $2.08M | $1.96M | $1.72M | $1.69M |
| Selling, General & Admin | $5.76M | $5.43M | $5.64M | $4.97M | $4.42M | $4.83M | $4.20M | $3.64M |
| **Operating Income** | -$409K | -$522K | -$276K | $185K | -$527K | -$2.01M | $4.50M | $732K |
| **EBITDA** | -$95K | -$222K | $65K | $542K | -$169K | -$1.61M | $4.90M | $1.13M |
| Income Before Tax | -$415K | -$495K | -$237K | $255K | -$452K | -$1.96M | $4.52M | $739K |
| Income Tax Expense | $11K | $172K | $42K | $18K | $14K | -$129K | $23K | $11K |
| **Net Income** | -$426K | -$667K | -$279K | $268K | -$466K | -$1.83M | $4.50M | $728K |
| Basic EPS | -$0.03 | -- | -$0.02 | $0.02 | -$0.03 | -- | $0.33 | $0.05 |
| **Diluted EPS** | -- | -- | -$0.02 | $0.02 | -$0.03 | -- | $0.31 | $0.05 |
| Basic Shares Outstanding | 13.9M | -- | 13.9M | 13.8M | 13.8M | -- | 13.7M | 13.6M |
| Diluted Shares Outstanding | -- | -- | 13.9M | 14.5M | 13.8M | -- | 14.4M | 14.0M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $4.87M | $9.79M | $2.62M | $10.12M | $9.01M | $4.69M | $8.34M | $3.24M | $856K | $3.29M |
| **Cash & Short-Term Investments** | $4.87M | $9.79M | $2.62M | $10.12M | $9.01M | $4.69M | $8.34M | $3.24M | $856K | $3.29M |
| Accounts Receivable, Net | $13.18M | $11.20M | $9.53M | $8.01M | $9.51M | $6.99M | $4.77M | $4.38M | $3.92M | $2.27M |
| **Total Current Assets** | $19.22M | $22.36M | $13.64M | $19.46M | $19.66M | $12.63M | $13.50M | $7.92M | $5.06M | $5.87M |
| Property, Plant & Equipment, Net | $3.53M | $4.38M | $5.72M | $7.19M | $7.13M | $6.09M | $3.99M | $2.55M | $2.08M | $1.22M |
| Goodwill | $335K | $335K | $335K | $335K | $335K | $335K | $335K | $669K | $669K | $669K |
| Other Non-Current Assets | $212K | $196K | $185K | $15K | $15K | $15K | $128K | $128K | $116K | $107K |
| **Total Non-Current Assets** | $7.77M | $9.99M | $12.49M | $14.85M | $15.71M | $14.96M | $7.25M | $3.34M | $3.02M | $2.14M |
| **Total Assets** | $26.99M | $32.34M | $26.13M | $34.31M | $35.38M | $27.59M | $20.75M | $11.27M | $8.08M | $8.01M |
| Accounts Payable | $6.90M | $4.25M | $5.80M | $5.33M | $2.87M | $1.89M | $3.14M | $2.81M | $2.15M | $1.85M |
| Deferred Revenue (Current) | $8.83M | $15.44M | $12.09M | $12.78M | $11.10M | $6.26M | $5.80M | $4.02M | $4.70M | $4.91M |
| Other Current Liabilities | $79K | $135K | $150K | $145K | $72K | $0 | -- | -- | -- | -- |
| **Total Current Liabilities** | $19.92M | $23.85M | $21.54M | $21.73M | $17.48M | $11.20M | $12.30M | $8.03M | $7.45M | $7.45M |
| Other Non-Current Liabilities | $7.0K | $85K | $401K | $551K | $391K | $181K | $178K | $151K | $151K | $164K |
| **Total Non-Current Liabilities** | $3.00M | $4.72M | $6.49M | $7.94M | $8.80M | $8.96M | $3.35M | $1.00M | $622K | $164K |
| **Total Liabilities** | $22.92M | $28.57M | $28.04M | $29.68M | $26.28M | $20.16M | $15.65M | $9.03M | $8.07M | $7.61M |
| **Total Debt (incl. Leases)** | $4.60M | $6.33M | $7.80M | $8.74M | $9.54M | $9.60M | $3.80M | -- | -- | -- |
| Common Stock | $14K | $14K | $14K | $14K | $14K | $13K | $13K | $12K | $11K | $11K |
| Retained Earnings | -$81.07M | -$79.89M | -$84.59M | -$77.32M | -$71.98M | -$72.53M | -$72.89M | -$70.70M | -$70.83M | -$69.35M |
| **Total Stockholders' Equity** | $3.94M | $3.77M | -$1.90M | $4.64M | $9.10M | $7.43M | $5.10M | $2.14M | $3.0K | $400K |
| Total Equity | $4.07M | $3.77M | -$1.90M | $4.64M | $9.10M | $7.43M | $5.10M | $2.14M | $3.0K | $400K |

### Balance Sheet (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $4.36M | $4.87M | $7.13M | $8.52M | $10.32M | $9.79M | $3.20M | $2.75M |
| **Cash & Short-Term Investments** | $4.36M | $4.87M | $7.13M | $8.52M | $10.32M | $9.79M | $3.20M | $2.75M |
| Accounts Receivable, Net | $13.60M | $13.18M | $12.07M | $11.54M | $9.47M | $11.20M | $15.78M | $10.47M |
| **Total Current Assets** | $19.29M | $19.22M | $20.18M | $21.33M | $21.01M | $22.36M | $19.70M | $14.08M |
| Property, Plant & Equipment, Net | $3.79M | $3.53M | $3.71M | $3.95M | $4.23M | $4.38M | $5.04M | $4.97M |
| Goodwill | $335K | $335K | $335K | $335K | $335K | $335K | $335K | $335K |
| Other Non-Current Assets | $201K | $212K | $196K | $196K | $196K | $196K | $185K | $185K |
| **Total Non-Current Assets** | $14.00M | $7.77M | $8.26M | $8.83M | $9.53M | $9.99M | $10.93M | $11.16M |
| **Total Assets** | $33.29M | $26.99M | $28.45M | $30.16M | $30.55M | $32.34M | $30.63M | $25.24M |
| Accounts Payable | $5.63M | $6.90M | $5.73M | $5.99M | $4.84M | $4.25M | $5.09M | $4.85M |
| Deferred Revenue (Current) | $9.55M | $8.83M | $10.00M | $12.34M | $14.43M | $15.44M | $10.92M | $10.22M |
| Other Current Liabilities | $234K | $79K | $78K | $97K | $116K | $135K | $154K | $151K |
| **Total Current Liabilities** | $18.73M | $19.92M | $20.68M | $22.14M | $22.70M | $23.85M | $19.87M | $18.86M |
| Other Non-Current Liabilities | $215K | $7.0K | $27K | $46K | $66K | $85K | $285K | $324K |
| **Total Non-Current Liabilities** | $10.10M | $3.00M | $3.39M | $3.79M | $4.31M | $4.72M | $5.29M | $5.70M |
| **Total Liabilities** | $28.83M | $22.92M | $24.07M | $25.93M | $27.01M | $28.57M | $25.16M | $24.56M |
| **Total Debt (incl. Leases)** | $10.32M | $4.60M | $5.00M | $5.41M | $5.93M | $6.33M | $6.70M | $7.07M |
| Common Stock | $14K | $14K | $14K | $14K | $14K | $14K | $14K | $14K |
| Retained Earnings | -$81.49M | -$81.07M | -$80.40M | -$80.12M | -$80.36M | -$79.89M | -$78.06M | -$82.55M |
| **Total Stockholders' Equity** | $3.89M | $3.94M | $4.28M | $4.17M | $3.51M | $3.77M | $5.47M | $681K |
| Total Equity | $4.46M | $4.07M | $4.38M | $4.23M | $3.54M | $3.77M | $5.47M | $681K |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$1.18M | $4.70M | -$7.28M | -$5.33M | $548K | $362K | -$2.09M | $128K | -$1.48M | -$6.88M |
| Depreciation & Amortization | $1.40M | $1.60M | $1.90M | $2.10M | $1.50M | $925K | $825K | $606K | $360K | $168K |
| Stock-Based Compensation | $1.24M | $654K | $1.12M | $864K | $912K | $598K | $600K | $636K | $1.00M | $2.66M |
| Change in Receivables | -$2.00M | -$1.44M | -$1.99M | $1.31M | -$2.82M | -$2.27M | -$670K | -$531K | -$1.60M | -$986K |
| Change in Payables | $2.56M | -$1.75M | $465K | $2.46M | $974K | -$1.25M | $333K | $653K | $301K | -$43K |
| **Operating Cash Flow** | -$4.47M | $7.39M | -$6.14M | $3.97M | $6.50M | -$1.68M | $2.90M | $1.86M | -$1.23M | -$2.84M |
| Capital Expenditure | -$564K | -$389K | -$836K | -$2.87M | -$2.38M | -$3.28M | -$2.22M | -$834K | -$1.23M | -$766K |
| **Free Cash Flow** | -$5.04M | $7.00M | -$6.97M | $1.10M | $4.11M | -$4.96M | $685K | $1.03M | -$2.46M | -$3.61M |
| **Investing Cash Flow** | -$540K | -$389K | -$836K | -$2.87M | -$2.38M | -$3.17M | -$2.22M | -$834K | -$1.23M | -$766K |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | -- | -- | $0 | $4.34M |
| Share Repurchases | -- | $0 | -$634K | -$74K | $0 | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $99K | $170K | -$527K | $11K | $207K | $1.20M | $4.42M | $1.20M | $13K | $4.32M |
| **Net Change in Cash** | -$4.91M | $7.17M | -$7.50M | $1.11M | $4.32M | -$3.65M | $5.11M | $2.23M | -$2.44M | $710K |

### Cash Flow Statement (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$426K | -$667K | -$278K | $237K | -$466K | -$1.83M | $4.50M | $728K |
| Depreciation & Amortization | $314K | $300K | $341K | $357K | $358K | $400K | $398K | $399K |
| Stock-Based Compensation | $766K | $357K | $423K | $249K | $208K | $131K | $256K | $9.0K |
| Change in Receivables | -$414K | -$1.19M | -$498K | -$2.08M | $1.76M | $4.50M | -$5.27M | -$1.23M |
| Change in Payables | -$1.43M | $1.27M | -$437K | $1.31M | $411K | -$614K | -$188K | -$382K |
| **Operating Cash Flow** | -$492K | -$2.00M | -$1.34M | -$1.74M | $600K | $6.87M | $490K | -$283K |
| Capital Expenditure | -$55K | -$239K | -$37K | -$242K | -$46K | -$253K | -$42K | -$94K |
| **Free Cash Flow** | -$547K | -$2.24M | -$1.38M | -$1.98M | $554K | $6.62M | $448K | -$377K |
| **Investing Cash Flow** | -$55K | -$238K | -$14K | -$242K | -$46K | -$253K | -$42K | -$94K |
| Share Repurchases | -- | -- | -- | -- | -- | $0 | $0 | $0 |
| **Financing Cash Flow** | $33K | -$19K | -$36K | $168K | -$14K | -$32K | $0 | $239K |
| **Net Change in Cash** | -$514K | -$2.25M | -$1.39M | -$1.81M | $540K | $6.58M | $448K | -$138K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 48.0% | 50.1% | 41.4% | 45.2% | 51.9% | 47.7% | 47.1% | -- | -- | -- |
| **Operating Margin** | -1.9% | 8.0% | -14.7% | -9.8% | 1.2% | 0.9% | -6.0% | 9.3% | -6.7% | -44.2% |
| **Net Profit Margin** | -2.0% | 8.3% | -14.5% | -9.9% | 1.1% | 0.9% | -6.5% | 4.4% | -7.3% | -44.7% |
| Return on Equity (ROE) | -29.8% | 124.6% | -- | -115.1% | 6.0% | 4.9% | -41.0% | 6.0% | -49200.0% | -1721.0% |
| Return on Assets (ROA) | -4.4% | 14.5% | -27.8% | -15.5% | 1.5% | 1.3% | -10.1% | 1.1% | -18.3% | -85.9% |
| Current Ratio | 0.96x | 0.94x | 0.63x | 0.90x | 1.13x | 1.13x | 1.10x | 0.99x | 0.68x | 0.79x |
| Quick Ratio | 0.91x | 0.88x | 0.56x | 0.83x | 1.06x | 1.04x | 1.07x | 0.95x | 0.64x | 0.75x |
| Debt to Equity | 1.17x | 1.68x | -- | 1.89x | 1.05x | 1.29x | 0.74x | -- | -- | -- |
| **Revenue Growth (YoY)** | +4.4% | +13.5% | -6.9% | +9.7% | +19.7% | +27.8% | +1007.7% | -85.7% | +31.3% | +37.8% |
| Gross Profit Growth (YoY) | -0.1% | +37.6% | -14.7% | -4.5% | +30.0% | +29.6% | -- | -- | -- | -- |
| Operating Income Growth (YoY) | -125.0% | -- | -- | -965.9% | +65.8% | -- | -811.5% | -- | -- | -- |
| **Net Income Growth (YoY)** | -125.0% | -- | -- | -1073.5% | +51.4% | -- | -1735.2% | -- | -- | -- |
| EPS Growth (YoY) | -123.5% | -- | -- | -1075.0% | +33.3% | -- | -1900.0% | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -160.5% | -- | -254.5% | -38.9% | -- | -157.9% | +56.0% | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -172.0% | -- | -733.9% | -73.3% | -- | -824.4% | -33.4% | -- | -- | -- |
| 5Y Revenue / Share Growth | +37.5% | +53.7% | +1347.7% | +116.0% | +158.0% | +142.9% | +83.2% | -87.7% | -4.1% | -21.3% |
| 10Y Revenue / Share Growth | +234.1% | +181.5% | +78.5% | +107.2% | +103.0% | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -408.3% | -- | -4858.2% | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 49.8% | 48.0% | 45.9% | 50.1% | 48.5% | 50.1% | 51.6% | 44.7% |
| **Operating Margin** | -1.7% | -1.9% | -4.5% | 3.7% | 4.7% | 8.0% | 10.7% | -1.5% |
| **Net Profit Margin** | -1.8% | -1.9% | -4.0% | 4.2% | 5.1% | 8.3% | 11.0% | -1.1% |
| Return on Equity (ROE) | -28.4% | -29.0% | -54.0% | 59.0% | 83.3% | 124.6% | 117.5% | -87.8% |
| Return on Assets (ROA) | -3.3% | -4.2% | -8.1% | 8.2% | 9.6% | 14.5% | 21.0% | -2.4% |
| Current Ratio | 1.03x | 0.96x | 0.98x | 0.96x | 0.93x | 0.94x | 0.99x | 0.75x |
| Quick Ratio | 0.96x | 0.91x | 0.93x | 0.91x | 0.87x | 0.88x | 0.96x | 0.70x |
| Debt to Equity | 2.65x | 1.17x | 1.17x | 1.30x | 1.69x | 1.68x | 1.22x | 10.38x |
| **Revenue Growth (YoY)** | +8.8% | +12.0% | -2.8% | +11.5% | -0.5% | -11.8% | +41.8% | +16.6% |
| Gross Profit Growth (YoY) | +28.3% | +38.2% | -25.9% | +28.2% | -14.2% | -24.7% | +149.9% | +22.3% |
| Operating Income Growth (YoY) | -- | -- | -106.1% | -74.7% | -139.7% | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -106.2% | -63.2% | -135.5% | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -106.1% | -60.0% | -130.0% | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -182.0% | -129.1% | -373.3% | -- | +92.9% | -- | -- | -148.0% |
| Free Cash Flow Growth (YoY) | -198.7% | -133.8% | -407.1% | -- | +78.1% | -- | -- | -173.9% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
